Imatinib: cancer-causing?
D000818:Animals; D005602:France; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D051381:Rats
D010879:Piperazines; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases